The purpose of the study was to examine the long-term influence of involuntary hospitalization on medication adherence, engagement in out-patient treatment and perceived coercion to treatment participation.
In a naturalistic observational multi-centre study, 290 voluntarily and 84 involuntarily hospitalized patients with schizophrenia or schizoaffective disorder had been followed up over a period of 2 years with half-yearly assessments. Assessments included self-rated medication adherence, externally judged medication adherence by blood levels, engagement in treatment and perceived coercion. The statistical analyses were based on multilevel hierarchical modelling of longitudinal data. Level and development of the outcome was controlled for involuntariness, for sociodemographic characteristics and clinical history.
Involuntariness of the index-hospitalization did not have an effect on the development of treatment engagement or medication adherence judged by blood levels in the course of the follow-up period when the models were controlled for sociodemographic variables and clinical history. It was associated, though, with a continuously lower self-rated medication adherence. Moreover, former involuntarily hospitalized patients more often felt coerced in several treatment aspects at the follow-up assessments. Yet, there was no difference between the voluntary and involuntary group with regard to the development of the levels of adherence or coercion experiences over time.
Involuntary hospitalization does not seem to impair future treatment engagement in patients with schizophrenia, but formerly involuntarily hospitalized patients continue to be more sensitive to subjective or real coercion in their treatment and more vulnerable to medication non-adherence. Hereby, their risk of future involuntary hospitalization might be increased.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Steinert T, Lepping P (2009) Legal provisions and practice in the management of violent patients. A case vignette study in 16 European countries. Eur Psychiatry 24:135–141
Zinkler M, Priebe S (2002) Detention of the mentally ill in Europe-a review. Acta Psychiatr Scand 106:3–8
Salize HJ, Dressing H (2004) Epidemiology of involuntary placement of mentally ill people across the European Union. Br J Psychiatry 184:163–168
Dressing H, Salize HJ (2004) Compulsory admission of mentally ill patients in European Union Member States. Soc Psychiatry Psychiatr Epidemiol 39:797–803
Sanguineti VR, Samuel SE, Schwartz SL, Robeson MR (1996) Retrospective study of 2,200 involuntary psychiatric admissions and readmissions. Am J Psychiatry 153:392–396
Bruns G (1991) Zwangseinweisungspatienten—eine psychiatrische Risikogruppe. Nervenarzt 62:308–312
Szmukler GI, Bird AS, Button EJ (1981) Compulsory admission in a London borough: I. Social and clinical features and a follow-up. Psychol Med 11:617–636
McEvoy JP, Applebaum PS, Apperson J, Geller JL, Freter S (1989) Why must some schizophrenic patients be involuntarily committed? The role of insight. Compr Psychiatry 30:13–17
Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA (2009) Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophrenia Bull 35:336–346
Priebe S, Katsakou C, Amos T, Leese M, Morriss R, Rose D, Wykes T, Yeeles K (2009) Patients’ views and readmissions 1 year after involuntary hospitalisation. Br J Psychiatry 194:49–54
O’Donoghue B, Lyne J, Hill M, Larkin C, Feeney L, O’Callaghan E (2010) Involuntary admission from the patients’ perspective. Soc Psychiatry Psychiatr Epidemiol 45:631–638
Oluwatayo O, Gater R (2004) The role of engagement with services in compulsory admission of African/Caribbean patients. Soc Psychiatry Psychiatr Epidemiol 39:739–743
Munk-Jørgensen P, Mortensen PB, Machón RA (1991) Hospitalization patterns in schizophrenia. A 13-year follow-up. Schizophr Res 4:1–9
Fennig S, Rabinowitz J, Fennig S (1999) Involuntary first admission of patients with schizophrenia as a predictor of future admissions. Psychiatr Serv 50:1049–1052
Van der Post LF, Peen J, Visch I, Mulder CL, Beekman AT, Dekker JJ (2013) Patient perspectives and the risk of compulsory admission: the Amsterdam study of acute psychiatry V. Int J Soc Psychiatry. doi:10.1177/0020764012470234 (epub ahead of print)
Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54:49–55
Kallert TW, Glöckner M, Schützwohl M (2008) Involuntary vs. voluntary hospital admission. A systematic literature review on outcome diversity. Eur Arch Psychiatry Clin Neurosci 258:195–209
Opjordsmoen S, Friis S, Melle I, Haahr U, Johannessen JO, Larsen TK, Røssberg JI, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2010) A 2-year follow-up of involuntary admission’s influence upon adherence and outcome in first-episode psychosis. Acta Psychiatr Scand 121:371–376
Kilian R, Steinert T, Schepp W, Weiser P, Jaeger S, Pfiffner C, Frasch K, Eschweiler GW, Messer T, Croissant D, Becker T, Längle G (2012) Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. Eur Arch Psychiatry Clin Neurosci 262:589–598
Längle G, Steinert T, Weiser P, Bayer W, Jaeger S, Pfiffner C, Frasch K, Eschweiler G, Messer T, Croissant D, Becker T, Kilian R (2012) Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment. Acta Psychiatr Scand 125:372–381
Frasch K, Weiser P, Becker T, Längle G, Steinert T, Niederreiner C, Pfiffner C, Jäger S, Bayer W, Eschweiler GW, Kilian R (2012) Psychotropic drug treatment, clinical characteristics and cognitive processing speed in patients with schizophrenia: results from the ELAN study. Pharmacopsychiatry 45:138–145
Jaeger S, Pfiffner C, Weiser P, Kilian R, Becker T, Längle G, Eschweiler GW, Croissant D, Schepp W, Steinert T (2012) Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study. Psychiatry Res 200:83–88
Kay SR, Opler LA, Lindemeyer JP (1998) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 155:59–65
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. DSM-IV-TR. 4th Edition, Text revision. American Psychiatric Association, Washington, DC
Jaeger S, Gebhardt RP, Pfiffner C, Bayer W, Weiser P, Wiesner H, Steinert T (2009) Akzeptanz und Umsetzung von Empfehlungen zur Rückfallverhütung–Entwicklung der Compliance Selbst-Rating Instrumente CSRI-E und CSRI-K. In: Schneider F, Grözinger M (eds) Psychische Erkrankungen in der Lebensspanne–Abstractband zum DGPPN Kongress 2009 in Berlin. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, Berlin
Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 42:241–247
Muthén B, Asparouhov T (2011) Beyond multilevel regression modeling: Multilevel analysis in a general latent variable framework. In: Hox JJ, Roberts JK (eds) Handbook of advanced multilevel analysis. Taylor and Francis, New York, pp 15–40
Muthén LK, Muthen BO (1998–2010) Mplus user’s guide. Sixth edition. Muthén & Muthén, Los Angeles, CA
Pieters V (2003) Macht—Zwang—Sinn Subjektives Erleben, Behandlungsbewertungen und Therapieerfolge bei gerichtlichen Unterbringungen schizophrener Patienten. Psychiatrie-Verlag, Bonn
Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, van Os J (2000) Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 102:203–210
Leung PK, Faulkner LR, McFarland BH, Riley C (1993) Indochinese patients in the civil commitment process. Bull Am Acad Psychiatry Law 21:81–89
De Haan L, van Amelsvoort T, Dingemans P, Linszen D (2007) Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective 5 year follow-up. Pharmacopsychiatry 40:264–268
Kortrijk HE, Staring AB, van Baars AW, Mulder CL (2010) Involuntary admission may support treatment outcome and motivation in patients receiving assertive community treatment. Soc Psychiatry Psychiatr Epidemiol 45:245–252
Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D (2008) A large-scale validation study of the medication adherence rating scale (MARS). Schizophr Res 100:53–59
Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, Rush AJ (2007) Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv 58:817–844
Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32:724–742
Wright EC (1993) Non-compliance–or how many aunts has Matilda? Lancet 342:909–913
Fenton WS, Blyler CR, Heinssen RK (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 23:637–651
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892–909
Day JC (2003) How reflections on concordance in mental health can affect research and clinical practice in adherence. Pharm J 271:505–507
Fleischhacker WW, Oehl MA, Hummer M (2003) Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 64(Suppl):S10–S13
Perkins DO (2002) Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63:1121–1128
Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ (2012) Medication adherence in schizophrenia. World J Psychiatr 2:74–82
Krivoy A, Fischel T, Zahalka H, Shoval G, Weizman A, Valevski A (2012) Outcomes of compulsorily admitted schizophrenia patients who agreed or disagreed to prolong their hospitalization. Compr Psychiatry 53:995–999
Nitzan U, Bukobza G, Aviram S, Fennig S, Lev-Ran S, Braw Y, Bloch Y (2013) Rebelliousness in patients suffering from schizophrenia-spectrum disorders. A possible predictor of attitudes towards medication. Psychiatry Res. doi:10.1016/j.psychres.2012.12.028 (epub ahead of print)
Rain SD, Williams VF, Robbins PC, Monahan J, Steadman HJ, Vesselinov R (2003) Perceived coercion at hospital admission and adherence to mental health treatment after discharge. Psychiatr Serv 54:103–105
Bindman J, Reid Y, Szmukler G, Tiller J, Thornicroft G, Leese M (2005) Perceived coercion at admission to psychiatric hospital and engagement with follow-up–a cohort study. Soc Psychiatry Psychiatr Epidemiol 40:160–166
The ELAN study was funded as an investigator-initiated research project by a grant from AstraZeneca Deutschland to the University of Tübingen (Project Nr. 229/2004V—Version 2, 27.09.04). AstraZeneca had no role in the development of the research questions, the design of the study, the collection, analyses and interpretation of data, and the writing of the manuscript. AstraZeneca had the right to comment on the final draft of the article before the submission to the journal. We wish to thank all participants who participated in the study. We also thank Heike Wiesner, Filiz Özfirat, Tanja Gieselmann and Simone Triem for data collection and data entry and Ildiko Baumgartner for her work in processing data.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jaeger, S., Pfiffner, C., Weiser, P. et al. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion. Soc Psychiatry Psychiatr Epidemiol 48, 1787–1796 (2013). https://doi.org/10.1007/s00127-013-0687-x
- Involuntary hospitalization
- Treatment engagement